Lysodren
Centrally authorised medicine · European Medicines Agency · Germany
-
EMA product number
EMEA/H/C/000521 -
ATC
L01XX23
What the source publishes
- Holder
- Esteve Pharmaceuticals, S.A.
- Administrative status
- authorised
Publisher documents
Names this record is found by
Complete source data
{
"inn": "mitotane",
"name": "Lysodren",
"holder": "Esteve Pharmaceuticals, S.A.",
"orphan": false,
"endDate": null,
"generic": false,
"smpcUrl": "https://www.ema.europa.eu/de/documents/product-information/lysodren-epar-product-information_de.pdf",
"species": null,
"atcCodes": [
"L01XX23"
],
"category": "Human",
"marketed": null,
"useDomain": "unknown",
"biosimilar": false,
"leafletUrl": "https://www.ema.europa.eu/de/documents/product-information/lysodren-epar-product-information_de.pdf",
"medicineUrl": "https://www.ema.europa.eu/en/medicines/human/EPAR/lysodren",
"decisionDate": "2026-02-13",
"sourceStatus": "Authorised",
"supplyRegime": null,
"opinionStatus": null,
"targetSpecies": [],
"suspensionDate": null,
"activeSubstance": "mitotane",
"advancedTherapy": false,
"lastUpdatedDate": "2026-03-11",
"reportTimestamp": "2026-11-08T18:01:45Z",
"therapeuticArea": "Adrenal Cortex Neoplasms",
"emaProductNumber": "EMEA/H/C/000521",
"authorisationDate": "2004-04-28",
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "de.ema.epar"
},
"patientEligibility": "not-assessed",
"productInformation": {
"url": "https://www.ema.europa.eu/de/documents/product-information/lysodren-epar-product-information_de.pdf",
"language": "de",
"updatedAt": "2026-03-11T11:11:00Z",
"englishUrl": "https://www.ema.europa.eu/en/documents/product-information/lysodren-epar-product-information_en.pdf"
},
"conditionalApproval": false,
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "unknown",
"exceptionalCircumstances": false,
"pharmacotherapeuticGroup": "Antineoplastic agents"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=de" \
--data-urlencode "sourceId=de.ema.epar" \
--data-urlencode "id=de:ema:epar:EMEA-H-C-000521"